No holdings information is available in our database.
Seeks to track, before fees and expenses, the LifeSci Biotechnology Products Index. The Index is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate that has received U.S. Food and Drug Administration approval.
$51.48 -1.11 (-2.10%)
As of 02/08/2023 15:54:17 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.